Trend Press Wire

Ophthalmic Drugs Market is Determined to Reach US$ 40 Billion by 2026

Press release   •   Jul 19, 2019 02:20 EDT

The Global Ophthalmic Drugs Market is anticipated to grow at 4.2 % CAGR during the forecast period 2019 – 2026 and reach around US$ 40 Billion by 2026. Acumen Research and Consulting provide a complete picture of industry trends and elements along with quantitative records based on historical data from a various number of sources.

Acumen Research and Consulting has recently published a research report on the Ophthalmic Drugs Market for the forecast period of 2019 to 2026, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Ophthalmic Drugs Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2026.

The research study on the Ophthalmic Drugs Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market, but also sheds light on the notable developments and future scope for innovation in the landscape.

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by ARC on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the Ophthalmic Drugs Market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1323

The report also analyzes the Ophthalmic Drugs Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Market Segmentation

By Drug Class Outlook

  • Antiallergy
  • Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents
  • Anti-inflammatory
    • Nonsteroidal Drugs
    • Steroidal Drugs
  • Antiglaucoma
  • Others

By Disease Outlook

  • Dry Eye
    • Gels
    • Eye Solutions
    • Capsules & Tablets
    • Eye Drops
    • Ointments
  • Allergies
    • Gels
    • Eye Solutions
    • Capsules & Tablets
    • Eye drops
    • Ointments
  • Glaucoma
    • Gels
    • Eye Solutions
    • Capsules & Tablets
    • Eye drops
    • Ointments
  • Inflammation/Infection
    • Gels
    • Eye Solutions
    • Capsules & Tablets
    • Eye drops
    • Ointments
  • Retinal Disorders
    • Gels
    • Eye Solutions
    • Capsules & Tablets
    • Eye drops
    • Ointments
  • Uveitis
    • Gels
    • Eye Solutions
    • Capsules & Tablets
    • Eye drops
    • Ointments
  • Others

By Dosage Form

  • Gels
  • Eye Solutions
  • Capsules & Tablets
  • Eye Drops
  • Ointments

By Product Type

  • Prescription Drugs
  • OTC Drugs

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on “Ophthalmic Drugs Market (By Drug Class Outlook: Antiallergy, Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents, Anti-inflammatory [Nonsteroidal Drugs, Steroidal Drugs], Antiglaucoma, Others; By Disease Outlook: Dry Eye [Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments], Allergies [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Glaucoma [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Inflammation/Infection [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Retinal Disorders [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Uveitis [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Others; By Dosage Form: Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments; By Product Type: Prescription Drugs, OTC Drugs) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Ophthalmic Drugs market segments with market dynamics and their impact. The report provides insights on global Ophthalmic Drugs market by Product, Dosage Form, Disease, Drug Class and major geographic regions. The report also covers basic technology development policies.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

The report on the Ophthalmic Drugs Market is based on an extensive and meticulous bottom up approach, which was used to determine the market size.

In the primary phase of the research methodology focus on, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the market.

Market Participants:

The Ophthalmic Drugs market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are ALLERGAN PLC ; Pfizer, Inc. ; Santen Pharmaceutical Co., Ltd. ; Johnson & Jean - Services, Inc. ; Merck Sharp & Dohme Corp. ; and Genentech, Inc. AG ; Bausch & Lomb, Inc. ; Regeneron Pharmaceutical, Inc., among others.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Ophthalmic Drugs
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Ophthalmic Drugs Market By Drug Class Outlook
1.2.2.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Drug Class Outlook (2015-2026)
1.2.2.2. Global Ophthalmic Drugs Market Revenue Share By Drug Class Outlook in 2017
1.2.2.3. Antiallergy
1.2.2.4. Anti-Vascular Endothelial Growth Factor (Anti-Vegf) Agents
1.2.2.5. Anti-inflammatory
1.2.2.5.1. Nonsteroidal Drugs
1.2.2.5.2. Steroidal Drugs
1.2.2.6. Antiglaucoma
1.2.2.7. Others
1.2.3. Ophthalmic Drugs Market By Disease Outlook
1.2.3.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Disease Outlook (2015-2026)
1.2.3.2. Global Ophthalmic Drugs Market Revenue Share By Disease Outlook in 2017
1.2.3.3. Dry Eye
1.2.3.4. Allergies
1.2.3.5. Glaucoma
1.2.3.6. Inflammation/Infection
1.2.3.7. Retinal Disorders
1.2.3.8. Uveitis
1.2.3.9. Others
1.2.4. Ophthalmic Drugs Market By Dosage Form
1.2.4.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
1.2.4.2. Global Ophthalmic Drugs Market Revenue Share By Dosage Form in 2017
1.2.4.3. Gels
1.2.4.4. Eye Solutions
1.2.4.5. Capsules & Tablets
1.2.4.6. Eye Drops
1.2.4.7. Ointments
1.2.4.8. Others
1.2.5. Ophthalmic Drugs Market By Product Type
1.2.5.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.5.2. Global Ophthalmic Drugs Market Revenue Share By Product Type in 2017
1.2.5.3. Prescription Drugs
1.2.5.4. OTC Drugs
1.2.5.5. Others
1.2.6. Ophthalmic Drugs Market by Geography
1.2.6.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Ophthalmic Drugs Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Ophthalmic Drugs Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Ophthalmic Drugs Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Ophthalmic Drugs Major Manufacturers in 2017

CHAPTER 4. Ophthalmic Drugs Market By Drug Class Outlook

4.1. Global Ophthalmic Drugs Revenue By Drug Class Outlook
4.2. Antiallergy
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Anti-Vascular Endothelial Growth Factor (Anti-Vegf) Agents
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Anti-inflammatory
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4.3. Nonsteroidal Drugs
4.4.4. Steroidal Drugs
4.5. Antiglaucoma
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Ophthalmic Drugs Market By Disease Outlook

5.1. Global Ophthalmic Drugs Revenue By Disease Outlook
5.2. Dry Eye
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Allergies
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Glaucoma
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Inflammation/Infection
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Retinal Disorders
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Uveitis
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Others
5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Ophthalmic Drugs Market By Dosage Form

6.1. Global Ophthalmic Drugs Revenue By Dosage Form
6.2. Gels
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Eye Solutions
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Capsules & Tablets
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Eye Drops
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Ointments
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Others
6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Ophthalmic Drugs Market By Product Type

7.1. Global Ophthalmic Drugs Revenue By Product Type
7.2. Prescription Drugs
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. OTC Drugs
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Others
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. North America Ophthalmic Drugs Market By Country

8.1. North America Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Ophthalmic Drugs Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. Europe Ophthalmic Drugs Market By Country

9.1. Europe Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. Asia-Pacific Ophthalmic Drugs Market By Country

10.1. Asia-Pacific Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. Latin America Ophthalmic Drugs Market By Country

11.1. Latin America Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. Middle East Ophthalmic Drugs Market By Country

12.1. Middle East Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 13. Africa Ophthalmic Drugs Market By Country

13.1. Africa Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. Allergan Plc
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Pfizer, Inc.
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Santen Pharmaceutical Co., Ltd.
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Johnson & Jean - Services, Inc.
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Merck Sharp & Dohme Corp.
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Genentech, Inc. AG
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Bausch & Lomb, Inc.
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. Regeneron Pharmaceutical, Inc.
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Others
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1323

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.